Astrana Health Inc. Common Stock (ASTH) — Analysis Summary
Astrana Health Inc. Common Stock (ASTH) has a market cap of $1.90B with year-over-year revenue growth of +56.4%. Net margin stands at 0.7%. The stock trades at a P/E ratio of 47.0.
Key Takeaways
- Revenue changed +56.4% year-over-year
- Net margin of 0.7%
- P/E ratio of 47.0
Compared to other companies in the SERVICES-MANAGEMENT CONSULTING SERVICES sector, ASTH posted revenue growth of +56.4% and trades at a P/E of 47.0.
Astrana Health Inc. Common Stock (ASTH)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at 1.5x — minimal debt service cushion
Debt/EBITDA at 5.7x — elevated leverage
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
Sector
SERVICES-MANAGEMENT CONSULTING SERVICES
Employees
3,000
Headquarters
ALHAMBRA, CA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.